Novavax
NVAX
#5691
Rank
A$1.97 B
Marketcap
A$11.96
Share price
-5.45%
Change (1 day)
14.92%
Change (1 year)

P/S ratio for Novavax (NVAX)

P/S ratio as of November 2026 (TTM): 3.21

According to Novavax's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -6.97. At the end of 2026 the company had a P/S ratio of 3.53.

P/S ratio history for Novavax from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20263.53242.18%
20251.03-46.96%
20241.94136.46%
20230.822231.11%
20220.6271-93.35%
20219.44-36.78%
202014.9116.33%
20196.90-66.56%
201820.638.17%
201714.9-32.93%
201622.3-64.37%
201562.535.26%
201446.2-9.57%
201351.1303.3%
201212.728.42%
20119.86-98.75%
2010787-4.14%
2009821567.88%
2008123-22.27%
2007158192.21%
200654.189.67%
200528.597.4%
200414.4-18.25%
200317.7286.66%
20024.57-66.51%
200113.6

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Novartis
NVS
5.27 64.10%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.59-19.56%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
4.57 42.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
2.26-29.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
0.8218-74.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
> 1000 442,101.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
2.14-33.27%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
1.99-37.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
0.4767-85.17%๐Ÿ‡บ๐Ÿ‡ธ USA